BMS’ Opdivo-Yervoy treatment improves survival in hepatocellular carcinoma trial
Patients in the dual immunotherapy arm had a median overall survival of 23.7 months.
Patients in the dual immunotherapy arm had a median overall survival of 23.7 months.
5 June marks World Environment Day, encouraging global awareness and action to protect the environment.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Massive Bio expands partnership with UEPM to boost access to oncology clinical trials
Vitestro’s robotic blood drawing device meets trial endpoints
IR-MED’s PressureSafe device cuts pressure injury incidence by half
AiM Medical Robotics partners with Harvard Hospital for DBS study